- Research article
Enhancement of wound closure in diabetic mice by ex vivo expanded cord blood CD34+ cells
Cellular & Molecular Biology Letters volume 18, pages 263–283 (2013)
Diabetes can impair wound closure, which can give rise to major clinical problems. Most treatments for wound repair in diabetes remain ineffective. This study aimed to investigate the influence on wound closure of treatments using expanded human cord blood CD34+ cells (CB-CD34+ cells), freshly isolated CB-CD34+ cells and a cytokine cocktail. The test subjects were mice with streptozotocin-induced diabetes. Wounds treated with fresh CB-CD34+ cells showed more rapid repair than mice given the PBS control. Injection of expanded CB-CD34+ cells improved wound closure significantly, whereas the injection of the cytokine cocktail alone did not improve wound repair. The results also demonstrated a significant decrease in epithelial gaps and advanced re-epithelialization over the wound bed area after treatment with either expanded CB-CD34+ cells or freshly isolated cells compared with the control. In addition, treatments with both CB-CD34+ cells and the cytokine cocktail were shown to promote recruitment of CD31+-endothelial cells in the wounds. Both the CB-CD34+ cell population and the cytokine treatments also enhanced the recruitment of CD68-positive cells in the early stages (day 3) of treatment compared with PBS control, although the degree of this enhancement was found to decline in the later stages (day 9). These results demonstrated that expanded CB-CD34+ cells or freshly isolated CB-CD34+ cells could accelerate wound repair by increasing the recruitment of macrophages and capillaries and the reepithelialization over the wound bed area. Our data suggest an effective role in wound closure for both ex vivo expanded CB-CD34+ cells and freshly isolated cells, and these may serve as therapeutic options for wound treatment for diabetic patients. Wound closure acceleration by expanded CB-CD34+ cells also breaks the insufficient quantity obstacle of stem cells per unit of cord blood and other stem cell sources, which indicates a broader potential for autologous transplantation.
hematopoietic stem cell
insulin-like growth factor
mesenchymal stem cell
plateletderived growth factor
stem cell factor
transforming growth factor-β
vascular endothelial growth factor
Pradhan, L., Nabzdyk, C., Andersen, N.D., LoGerfo, F.W. and Veves, A. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev. Mol. Med. 11 (2009) e2.
Danaei, G., Finucane, M.M., Lu, Y., Singh, G.M., Cowan, M.J., Paciorek, C.J., Lin, J.K., Farzadfar, F., Khang, Y.H., Stevens, G.A., Rao, M., Ali, M.K., Riley, L.M., Robinson, C.A. and Ezzati, M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378 (2011) 31–40.
Junrungsee, S., Kosachunhanun, N., Wongthanee, A. and Rerkasem, K. History of foot ulcers increases mortality among patients with diabetes in Northern Thailand. Diabet. Med. 28 (2011) 608–611.
Iversen, M.M., Tell, G.S., Riise, T., Hanestad, B.R., Ostbye, T., Graue, M. and Midthjell, K. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trondelag Health Study, Norway. Diabetes Care 32 (2009) 2193–2199.
Broughton, G., 2nd, Janis, J.E. and Attinger, C.E. The basic science of wound healing. Plast. Reconstr. Surg. 117 (2006) 12S–34S.
Blakytny, R. and Jude, E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet. Med. 23 (2006) 594–608.
Tsuboi, R., Shi, C.M., Sato, C., Cox, G.N. and Ogawa, H. Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. J. Invest. Dermatol. 104 (1995) 199–203.
Roberts, A.B. Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen. 3 (1995) 408–418.
Heldin, C.H. and Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79 (1999) 1283–1316.
Muangman, P., Muffley, L.A., Anthony, J.P., Spenny, M.L., Underwood, R.A., Olerud, J.E. and Gibran, N.S. Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen. 12 (2004) 44–52.
Behm, B., Babilas, P., Landthaler, M. and Schreml, S. Cytokines, chemokines and growth factors in wound healing. J. Eur. Acad. Dermatol. Venereol. 26 (2012) 812–820.
Barrientos, S., Stojadinovic, O., Golinko, M.S., Brem, H. and Tomic-Canic, M. Growth factors and cytokines in wound healing. Wound Repair Regen. 16 (2008) 585–601.
Gary Sibbald, R. and Woo, K.Y. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab. Res. Rev. 24Suppl 1 (2008) S25–30.
Lamers, M.L., Almeida, M.E., Vicente-Manzanares, M., Horwitz, A.F. and Santos, M.F. High glucose-mediated oxidative stress impairs cell migration. PLoS ONE 6 (2011) e22865–22873.
Smith, P.G. and Liu, M. Impaired cutaneous wound healing after sensory denervation in developing rats: effects on cell proliferation and apoptosis. Cell Tissue Res. 307 (2002) 281–291.
Kondo, M., Wagers, A.J., Manz, M.G., Prohaska, S.S., Scherer, D.C., Beilhack, G.F., Shizuru, J.A. and Weissman, I.L. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21 (2003) 759–806.
Otrock, Z.K., Mahfouz, R.A., Makarem, J.A. and Shamseddine, A.I. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol. Dis. 39 (2007) 212–220.
Majka, M., Janowska-Wieczorek, A., Ratajczak, J., Ehrenman, K., Pietrzkowski, Z., Kowalska, M.A., Gewirtz, A.M., Emerson, S.G. and Ratajczak, M.Z. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/ paracrine manner. Blood 97 (2001) 3075–3085.
Sivan-Loukianova, E., Awad, O.A., Stepanovic, V., Bickenbach, J. and Schatteman, G.C. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J. Vasc. Res. 40 (2003) 368–377.
Caballero, S., Sengupta, N., Afzal, A., Chang, K.H., Li Calzi, S., Guberski, D.L., Kern, T.S. and Grant, M.B. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 56 (2007) 960–967.
Chan, R.K., Garfein, E., Gigante, P.R., Liu, P., Agha, R.A., Mulligan, R. and Orgill, D.P. Side population hematopoietic stem cells promote wound healing in diabetic mice. Plast. Reconstr. Surg. 120 (2007) 407–411; discussion 412–413.
Barcelos, L.S., Duplaa, C., Krankel, N., Graiani, G., Invernici, G., Katare, R., Siragusa, M., Meloni, M., Campesi, I., Monica, M., Simm, A., Campagnolo, P., Mangialardi, G., Stevanato, L., Alessandri, G., Emanueli, C. and Madeddu, P. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ. Res. 104 (2009) 1095–1102.
Pedroso, D.C., Tellechea, A., Moura, L., Fidalgo-Carvalho, I., Duarte, J., Carvalho, E. and Ferreira, L. Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells. PLoS ONE 6 (2011) e16114.
Elsharawy, M.A., Naim, M. and Greish, S. Human CD34+ stem cells promote healing of diabetic foot ulcers in rats. Interact. Cardiovasc. Thorac. Surg. 14 (2012) 288–293.
Motyl, K. and McCabe, L.R. Streptozotocin, type I diabetes severity and bone. Biol. Proced. Online 11 (2009) 296–315.
Nishio, Y., Koda, M., Kamada, T., Someya, Y., Yoshinaga, K., Okada, S., Harada, H., Okawa, A., Moriya, H. and Yamazaki, M. The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. J. Neurosurg. Spine 5 (2006) 424–433.
Templin, C., Grote, K., Schledzewski, K., Ghadri, J.R., Schnabel, S., Napp, L.C., Schieffer, B., Kurzen, H., Goerdt, S., Landmesser, U., Koenen, W. and Faulhaber, J. Ex vivo expanded haematopoietic progenitor cells improve dermal wound healing by paracrine mechanisms. Exp. Dermatol. 18 (2009) 445–453.
Badillo, A.T., Redden, R.A., Zhang, L., Doolin, E.J. and Liechty, K.W. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure. Cell Tissue Res. 329 (2007) 301–311.
Snarski, E., Milczarczyk, A., Torosian, T., Paluszewska, M., Urbanowska, E., Krol, M., Boguradzki, P., Jedynasty, K., Franek, E. and Wiktor-Jedrzejczak, W. Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I. Bone Marrow Transplant. 46 (2011) 562–566.
Couri, C.E., Oliveira, M.C., Stracieri, A.B., Moraes, D.A., Pieroni, F., Barros, G.M., Madeira, M.I., Malmegrim, K.C., Foss-Freitas, M.C., Simoes, B.P., Martinez, E.Z., Foss, M.C., Burt, R.K. and Voltarelli, J.C. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301 (2009) 1573–1579.
Feng, K., Xu, Y.W., Ye, F.G., Xiao, L., Ma, X.H., Gao, Y., Zhang, X., Yao, S.Z. and Shi, B.Y. [Autologous peripheral blood hematopoietic stem cell transplantation in the treatment of type 1 diabetic mellitus: a report of 16 cases]. Zhonghua Yi Xue Za Zhi 91 (2011) 1966–1969.
Singer, A.J. and Clark, R.A. Cutaneous wound healing. N. Engl. J. Med. 341 (1999) 738–746.
Kim, J.Y., Song, S.H., Kim, K.L., Ko, J.J., Im, J.E., Yie, S.W., Ahn, Y.K., Kim, D.K. and Suh, W. Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Cell Transplant. 19 (2010) 1635–1644.
Broughton, G.I., Janis, J.E. and Attinger, C.E. Wound Healing: An Overview. Plast. Reconstr. Surg. 117 (2006) 1e-S–32e-S.
Di Rocco, G., Gentile, A., Antonini, A., Ceradini, F., Wu, J.C., Capogrossi, M.C. and Toietta, G. Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int. 2011 (2010) 304562.
Zhang, S., Anderson, D.F., Bradding, P., Coward, W.R., Baddeley, S.M., MacLeod, J.D., McGill, J.I., Church, M.K., Holgate, S.T. and Roche, W.R. Human mast cells express stem cell factor. J. Pathol. 186 (1998) 59–66.
Longley, B.J., Jr., Morganroth, G.S., Tyrrell, L., Ding, T.G., Anderson, D.M., Williams, D.E. and Halaban, R. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N. Engl. J. Med. 328 (1993) 1302–1307.
Weiss, R.R., Whitaker-Menezes, D., Longley, J., Bender, J. and Murphy, G.F. Human dermal endothelial cells express membrane-associated mast cell growth factor. J. Invest. Dermatol. 104 (1995) 101–106.
Huttunen, M., Naukkarinen, A., Horsmanheimo, M. and Harvima, I.T. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing. Arch. Dermatol. Res. 294 (2002) 324–330.
Lam, C.R., Tan, M.J., Tan, S.H., Tang, M.B., Cheung, P.C. and Tan, N.S. TAK1 regulates SCF expression to modulate PKBalpha activity that protects keratinocytes from ROS-induced apoptosis. Cell Death Differ. 18 (2011) 1120–1129.
Morita, E., Tanaka, T., Shinoda, S., Kameyoshi, Y., Yamamoto, S., Lee, D.G. and Sugiyama, M. Expression of multiple forms of fetal liver kinase-2 (flk-2/flt-3) ligand in cultured human keratinocytes. Arch. Dermatol. Res. 289 (1997) 177–179.
Bohannon, J., Cui, W., Cox, R., Przkora, R., Sherwood, E. and Toliver-Kinsky, T. Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection. J. Immunol. 180 (2008) 3038–3048.
Bohannon, J., Cui, W., Sherwood, E. and Toliver-Kinsky, T. Dendritic cell modification of neutrophil responses to infection after burn injury. J. Immunol. 185 (2010) 2847–2853.
Toliver-Kinsky, T.E., Cui, W., Murphey, E.D., Lin, C. and Sherwood, E.R. Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection. J. Immunol. 174 (2005) 404–410.
Ghazizadeh, M. Essential role of IL-6 signaling pathway in keloid pathogenesis. J. Nihon Med. Sch. 74 (2007) 11–22.
Paquet, P. and Pierard, G.E. Interleukin-6 and the skin. Int. Arch. Allergy Immunol. 109 (1996) 308–317.
Sawamura, D., Meng, X., Ina, S., Sato, M., Tamai, K., Hanada, K. and Hashimoto, I. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. J. Immunol. 161 (1998) 5633–5639.
Lee, M.J., Kim, J., Lee, K.I., Shin, J.M., Chae, J.I. and Chung, H.M. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy 13 (2011) 165–178.
Cheon, S.S., Cheah, A.Y., Turley, S., Nadesan, P., Poon, R., Clevers, H. and Alman, B.A. beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc. Natl. Acad. Sci. USA 99 (2002) 6973–6978.
Cheon, S., Poon, R., Yu, C., Khoury, M., Shenker, R., Fish, J. and Alman, B.A. Prolonged beta-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds. Lab. Invest. 85 (2005) 416–425.
Fathke, C., Wilson, L., Shah, K., Kim, B., Hocking, A., Moon, R. and Isik, F. Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biol. 7 (2006) 4.
Slavik, M.A., Allen-Hoffmann, B.L., Liu, B.Y. and Alexander, C.M. Wnt signaling induces differentiation of progenitor cells in organotypic keratinocyte cultures. BMC Dev. Biol. 7 (2007) 9.
Kim, D.W., Lee, J.S., Yoon, E.S., Lee, B.I., Park, S.H. and Dhong, E.S. Influence of human adipose-derived stromal cells on Wnt signaling in organotypic skin culture. J. Craniofac. Surg. 22 (2011) 694–698.
Janowska-Wieczorek, A., Majka, M., Ratajczak, J. and Ratajczak, M.Z. Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 19 (2001) 99–107.
Electronic supplementary material
About this article
Cite this article
Chotinantakul, K., Dechsukhum, C., Dejjuy, D. et al. Enhancement of wound closure in diabetic mice by ex vivo expanded cord blood CD34+ cells. Cell Mol Biol Lett 18, 263–283 (2013). https://doi.org/10.2478/s11658-013-0089-9
- CD31+ cells
- CD34+ cells
- CD68+ cells
- Cord blood
- Diabetic mice
- Ex vivo expansion
- Hematopoietic stem cells
- Stem cell therapy
- Wound closure